Teladoc Health, Inc.TDOCNYSE
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-11.83%
↓ 123% below average
Average (9y)
51.96%
Historical baseline
Range
High:155.15%
Low:-11.83%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -11.83% |
| 2023 | 4.46% |
| 2022 | 6.97% |
| 2021 | 89.09% |
| 2020 | 155.15% |
| 2019 | 18.89% |
| 2018 | 57.79% |
| 2017 | 57.96% |
| 2016 | 53.52% |
| 2015 | 87.64% |